Skip to content
Wednesday, November 11, 2026
Insider Central Plus

The Zimbabwean Government Rejects ‘Unbalanced’ American Healthcare Assistance Package Over Data Fears

Medical funding illustration
The proposed American financial assistance was intended for programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has rejected a substantial US health deal worth 367 million US dollars (£272m) over five years over Washington's demand for sensitive information.

This rejection became public after a government memo from December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".

An official spokesman later clarified that the US was demanding access to genetic material for research and commercial purposes while was unwilling to share the benefits from any future medical innovations.

"We must now begin the difficult and regrettable process of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had provided over $1.9bn as health assistance to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has urged more negotiations to reach a deal acceptable to all parties so the nation's vital HIV programme can proceed.

Wider Background

This rejection follows a similar situation in Kenya, where a court halted a related health funding agreement following legal challenges were raised about the security of Kenyans' medical information.

After returning to the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

USAID had managed aid for the US government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government deals to boost transparency and responsibility.

Based on reports, Sixteen nations in Africa have so far signed similar agreements, constituting more than $18.3bn in new funding.

Details of the Declined Deal

This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this cooperation could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million currently receiving HIV treatment through American-funded initiatives," the Ambassador added.

However, official spokesman Nick Mangwana argued the arrangement was "unequal".

"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any equivalent promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.

"Put simply, our nation would supply the raw materials for medical research without any assurance that the end products would be available to our population should a future disease outbreak arise."

Sovereignty and International Frameworks

He also noted that the US's withdrawal from the global health body and its push of bilateral deals were undermining systems already set up via the global organization.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.

"This framework is designed to guarantee that when a country provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."

Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.

"We welcome further discussions with our American counterparts on how subsequent collaboration might be arranged in a manner that respects the sovereignty and interests of each country."

Health Experts Reaction

Medical experts expressed it understood the official position, but suggested that talks need to persist considering much of the country's HIV programmes depended on foreign aid.

"If specific concerns arise, such as those involving information security or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," it said.

The situation underscores the continuing challenges between receiving much-needed foreign assistance and protecting local interests in an ever more data-driven world.

The writer

Johnathan Roberson

A seasoned business analyst with over a decade of experience covering UK markets and corporate strategies.

Insider Central Plus

Type to search articles.